TY - JOUR
T1 - Immunoregulation by naturally occurring and disease-associated autoantibodies
T2 - binding to cytokines and their role in regulation of T-cell responses
AU - Nielsen, Claus H
AU - Bendtzen, Klaus
PY - 2012
Y1 - 2012
N2 - The role of naturally occurring autoantibodies (NAbs) in homeostasis and in disease manifestations is poorly understood. In the present chapter, we review how NAbs may interfere with the cytokine network and how NAbs, through formation of complement-activating immune complexes with soluble self-antigens, may promote the uptake and presentation of self-molecules by antigen-presenting cells. Both naturally occurring and disease-associated autoantibodies against a variety of cytokines have been reported, including NAbs against interleukin (IL)-1α, IL-6, IL-8, IL-10, granulocyte-macrophage colony-stimulating factor, interferon (IFN)-α, IFN-β, IFN-γ, macrophage chemotactic protein-1 and IL-21. NAbs against a variety of other self-antigens have also been reported, and using thyroglobulin as an example we discuss how NAbs are capable of promoting uptake of immune complexes via complement receptors and Fc-receptors on antigen-presenting cells and thereby regulate T-cell activity. Knowledge of the influence of NAbs against cytokines on immune homeostasis is likely to have wide-ranging implications both in understanding pathogenesis and in treatment of many immunoinflammatory disorders, including a number of autoimmune and autoinflammatory diseases.
AB - The role of naturally occurring autoantibodies (NAbs) in homeostasis and in disease manifestations is poorly understood. In the present chapter, we review how NAbs may interfere with the cytokine network and how NAbs, through formation of complement-activating immune complexes with soluble self-antigens, may promote the uptake and presentation of self-molecules by antigen-presenting cells. Both naturally occurring and disease-associated autoantibodies against a variety of cytokines have been reported, including NAbs against interleukin (IL)-1α, IL-6, IL-8, IL-10, granulocyte-macrophage colony-stimulating factor, interferon (IFN)-α, IFN-β, IFN-γ, macrophage chemotactic protein-1 and IL-21. NAbs against a variety of other self-antigens have also been reported, and using thyroglobulin as an example we discuss how NAbs are capable of promoting uptake of immune complexes via complement receptors and Fc-receptors on antigen-presenting cells and thereby regulate T-cell activity. Knowledge of the influence of NAbs against cytokines on immune homeostasis is likely to have wide-ranging implications both in understanding pathogenesis and in treatment of many immunoinflammatory disorders, including a number of autoimmune and autoinflammatory diseases.
KW - Antigen-Presenting Cells
KW - Autoantibodies
KW - Autoantigens
KW - Autoimmune Diseases
KW - Communicable Diseases
KW - Complement Activation
KW - Complement System Proteins
KW - Cytokines
KW - Humans
KW - Inflammation
KW - Protein Binding
KW - Receptors, Complement
KW - Receptors, Fc
KW - T-Lymphocytes
KW - Thyroglobulin
U2 - 10.1007/978-1-4614-3461-0_9
DO - 10.1007/978-1-4614-3461-0_9
M3 - Journal article
C2 - 22903670
SN - 0065-2598
VL - 750
SP - 116
EP - 132
JO - Advances in Experimental Medicine and Biology
JF - Advances in Experimental Medicine and Biology
ER -